JPI InvestFrançais
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool's data · not financial advice · full analysis (free)
All stocksHealth CareLGND › Financials

Ligand Pharmaceuticals, Inc. (LGND): financial analysis & fundamentals

Health Care · price $285 · market cap —
In short — Ligand Pharmaceuticals, Inc. trades at —× earnings (P/E), —× expected earnings, for a PEG of — and a net margin of —. Revenue growth . Quick verdict: valuation to review.

📈 See the interactive version (live chart) →

🔗 Related pages on Ligand Pharmaceuticals, Inc. — Are analysts right?  ·  If I had invested

Valuation & profitability

MetricValueWhat it means
P/E (price / earnings)The higher, the more growth the market expects.
Forward P/EOn next year's expected earnings. Lower than current P/E = rising earnings.
PEG (P/E ÷ growth)Below 1 = cheap given growth; above 2 = expensive.
Net marginShare of revenue that ends up as profit.
Revenue growthPace of revenue growth.
Price-to-bookPrice relative to book value.
Market capTotal market value of the company.
Dividend yieldNo dividend currently.

📊 Open the interactive Ligand Pharmaceuticals, Inc. page (charts, live news) →

Frequently asked questions

Is Ligand Pharmaceuticals, Inc. stock expensive?

Ligand Pharmaceuticals, Inc. has a P/E of — (forward P/E —) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.

What is Ligand Pharmaceuticals, Inc.'s net margin?

Ligand Pharmaceuticals, Inc.'s net margin is about — — the share of revenue that ends up as net profit.

What is Ligand Pharmaceuticals, Inc.'s revenue?

Ligand Pharmaceuticals, Inc.'s income statement is detailed on this page.

What is Ligand Pharmaceuticals, Inc.'s market cap?

Ligand Pharmaceuticals, Inc. (LGND) has a market cap of about —.

Does Ligand Pharmaceuticals, Inc. pay a dividend?

No, Ligand Pharmaceuticals, Inc. does not currently pay a dividend (it reinvests earnings).

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.